This protocol describes two options for the native (nondenaturing) elution of protein complexes obtained by affinity capture. The first approach involves the elution of complexes purified through a tag that includes a human rhinovirus 3C protease (PreScission protease) cleavage site sequence between the protein of interest and the tag. Incubation with the protease cleaves immobilized complexes from the affinity medium. The second approach involves the release of protein A-tagged protein complexes using a competitive elution reagent called PEGylOx. The degree of purity of the native assemblies eluted is sample dependent and strongly influenced by the affinity capture. It should be noted that the efficiency of native elution is commonly lower than that of elution by a denaturing agent (e.g., SDS) and the release of the complex will be limited by the activity of the protease or the inhibition constant (K i ) of the competitive release agent. However, an advantage of native release is that some nonspecifically bound materials tend to stay adsorbed to the affinity medium, providing an eluted fraction of higher purity. Finally, keep in mind that the presence of the protease or elution peptide could potentially affect downstream applications; thus, their removal should be considered.
peptide is 2 mM (which will be solvent dependent), effective elution can be expected. We recommend using a 40 mM Tris-Cl buffered elution solution at pH 8.0 and ethanol at 5% (v/v) in any elution solution. Na-HEPES at pH 7.4 can be substituted for Tris-Cl. As a detergent, we use Tween 20 at 0.01% (v/v); a detergent is required for stable high concentration solutions of PEGylOx. The concentration of the peptide solution is monitored by UV spectrophotometry at 280 nm using an estimated molar extinction coefficient (ε280) of 11,125 M −1 cm −1 . 
Native Elution of Protein Complexes Using a Cleavable Tag
This protocol is suitable for eluting complexes purified through a tag that includes a human rhinovirus 3C protease (PreScission protease) cleavage site sequence (GLEVLFQGPS) between the protein of interest and the tag (Cordingley et al. 1989 (Cordingley et al. , 1990 Walker et al. 1994) . This approach has also been successful using a cleavage site for tobacco etch virus protease (Dougherty et al. 1989; Polayes et al. 1994 ).
1. Prepare 1.25 µL of digestion mixture (PreScission protease in digestion buffer at a concentration of 0.08 units/µL) per 5 µL of Dynabeads slurry used in the affinity capture. This solution will be added directly to the beads containing immobilized complexes obtained at the end of Step 11 in Protocol: Optimized Affinity Capture of Yeast Protein Complexes . Keep the digestion mixture on ice.
We suggest preparing a small excess of digestion mixture to compensate for pipetting errors. If the protease activity (units) is not known, try 0.08 µg/μL.
If the digestion buffer is different from the wash buffer used in
Step 11 5. Centrifuge the sample at 3500g for 1 min at 4˚C to pellet the beads. Place the tube in the magnet, and transfer the supernatant to a clean tube on ice. 6. Add digestion buffer (no enzyme) to the beads. Use 1 µL per 5 µL of Dynabeads slurry used in the affinity capture. Tap the tube until the beads are fully resuspended. Do not vortex. 7. Centrifuge the sample at 3500g for 1 min at 4˚C to pellet the beads. Place the tube in the magnet, and transfer the supernatant to the same tube that contains supernatant from Step 5.
8. Centrifuge the combined eluted fraction at 20,000g for 10 min at 4˚C to pellet residual magnetic beads and particulates. 9. Transfer the supernatant to a clean tube-this is the natively eluted material.
The sample should be used as soon as possible to avoid disintegration of the purified complex, but depending on the stability of the complex the sample could be held on ice or at 4˚C for up to several hours if further processing by, for example, density gradient centrifugation will be carried out. The sample may be stored at −20˚C or lower for longer term, but freeeze-thaw cycles may adversely affect native structures. Consider the addition of a cryoprotectant such as glycerol or ethylene glycol to the sample before storage at −20˚C if, for example, enzymatic assays will be conducted on the sample. If the material is not going to be used immediately in subsequent procedures, consider adding PreScission protease inhibitors to the sample. The manufacturer suggests 4 mM Pefabloc or 100 µM chymostatin.
To prepare a more homogeneous solution of protein complexes (i.e., one without fragments caused by degradation during the purification procedure), subject the eluate to rate-zonal density gradient ultracentrifugation as described in Protocol: Density Gradient Ultracentrifugation to Isolate Endogenous Protein Complexes after Affinity Capture .
Analyze a fraction of this sample by SDS-PAGE as in
Step 12 in Protocol: Optimized Affinity Capture of Yeast Protein Complexes .
To determine what material remains on the beads after protease cleavage, wash the Dynabeads with SDS-PAGE sample loading buffer.
See Troubleshooting.
Native Elution of Protein A-Tagged Complexes Using the Competitive Elution Reagent PEGylOx
This procedure uses a synthetic peptide, PEGylOx, whose production, handling and usage is described in LaCava et al. (2013) . The peptide competitively releases protein A-tagged complexes from interaction with the IgG constant (Fc) region, and it can be removed from the eluted fraction by spin column gel filtration.
Wash protein complexes immobilized on Dynabeads (from the last wash in Step 11 in Protocol:
Optimized Affinity Capture of Yeast Protein Complexes ) with 50 µL of the solution used to dissolve PEGylOx, and then remove the wash solution. Fifty microliters of solution is sufficient for up to 25 μL of Dynabeads slurry used in the affinity capture. Scale up the wash if necessary.
This step is to equilibrate the beads with the elution solution, while keeping the beads and complexes highly concentrated. It can be omitted if the elution solution and the extraction solvent are the same.
12. Add 26 µL of PEGylOx native elution solution to up to 25 µL of the Dynabeads slurry; scale up as needed. Incubate with gentle shaking (e.g., setting three on a vortex mixer) for 15 min at room temperature. 13. Apply a brief pulse of low-speed centrifugation to ensure all of the slurry is at the bottom of the tube. Place the tube in the magnet, and transfer the supernatant to a clean tube. To ensure no beads have carried over, place the sample on the magnet again, and transfer the supernatant to a fresh tube-this is the natively eluted material.
The samples should be used as soon as possible to avoid disintegration of the purified complex, but depending on the stability of the complex the sample could be held on ice or 4˚C for up to several hours if further processing by, for example, PEGylOx removal and/or density gradient centrifugation will be carried out. The sample may be stored at −20˚C or lower for longer term, but freeze-thaw cycles may adversely affect native structures. Consider the addition of a cryoprotectant such as glycerol or ethylene glycol to the sample prior to storage at −20˚C if, for example, enzymatic assays will be conducted on the sample. Bear in mind that PEGylox solubility at low temperatures may vary with the composition of the elution solution used-the PEGylOx solution compositions suggested in Materials are stable at the above storage temperatures.
14. (Optional) To deplete the peptide >100-fold, apply the natively eluted samples to gel filtration spin columns with a nominal molecular mass cutoff of 40 kDa. Pre-equilibrate these columns with the desired buffer solution for exchange following the manufacturer's instructions. If necessary, use this step as an opportunity to exchange the solution the sample is in for downstream assays. Consider using low protein-binding tubes to collect the flowthrough.
